Total Payments
$2,132
2024 Payments
$856.23
Companies
20
Transactions
115
Medicare Patients
204
Medicare Billing
$12,410
Payment Breakdown by Category
Food & Beverage$2,132 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,132 | 115 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $302.57 | 11 | $0 (2024) |
| PFIZER INC. | $281.99 | 19 | $0 (2024) |
| Novo Nordisk Inc | $275.83 | 16 | $0 (2024) |
| GlaxoSmithKline, LLC. | $180.68 | 10 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $173.93 | 11 | $0 (2024) |
| Lilly USA, LLC | $131.22 | 5 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $122.95 | 8 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $99.43 | 6 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $77.97 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $77.57 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $856.23 | 39 | Novartis Pharmaceuticals Corporation ($212.79) |
| 2023 | $676.78 | 39 | Novo Nordisk Inc ($106.78) |
| 2022 | $352.26 | 20 | E.R. Squibb & Sons, L.L.C. ($64.24) |
| 2021 | $246.81 | 17 | PFIZER INC. ($115.81) |
All Payment Transactions
115 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | VYNDAMAX (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: UROLOGY | ||||||
| 11/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Neuroscience | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: PSYCHIATRY | ||||||
| 11/04/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Neuroscience | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $31.96 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $32.29 | General |
| Category: NEUROLOGY | ||||||
| 10/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Cardio-renal | ||||||
| 09/09/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $27.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/05/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Neuropsychiatry | ||||||
| 08/29/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $28.07 | General |
| Category: PSYCHIATRY | ||||||
| 08/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Diabetes | ||||||
| 07/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: RESPIRATORY | ||||||
| 06/27/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $24.06 | General |
| Category: PSYCHIATRY | ||||||
| 06/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Cardio-renal | ||||||
| 06/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Diabetes | ||||||
| 06/03/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $34.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/20/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $32.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/16/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: Biological | ||||||
| 05/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Cardio-renal | ||||||
| 04/29/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $31.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 18 | 18 | $4,194 | $1,432 |
| 2022 | 1 | 12 | 12 | $2,796 | $1,485 |
| 2021 | 4 | 74 | 77 | $7,264 | $3,896 |
| 2020 | 3 | 100 | 106 | $12,114 | $5,597 |
Total Patients
204
Total Services
213
Medicare Billing
$12,410
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $4,194 | $1,432 | 34.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 12 | 12 | $2,796 | $1,485 | 53.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 23 | 24 | $2,992 | $1,776 | 59.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 12 | 12 | $2,796 | $1,279 | 45.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 14 | $1,260 | $759.98 | 60.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 25 | 27 | $216.00 | $81.00 | 37.5% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 34 | 34 | $7,922 | $3,479 | 43.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 27 | 32 | $3,872 | $1,998 | 51.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 39 | 40 | $320.00 | $119.28 | 37.3% |
About Jiyoung Chae
Jiyoung Chae is a Registered Nurse healthcare provider based in West Lafayette, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2015. The National Provider Identifier (NPI) number assigned to this provider is 1568845295.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jiyoung Chae has received a total of $2,132 in payments from pharmaceutical and medical device companies, with $856.23 received in 2024. These payments were reported across 115 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($2,132).
As a Medicare-enrolled provider, Chae has provided services to 204 Medicare beneficiaries, totaling 213 services with total Medicare billing of $12,410. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Registered Nurse
- Other Specialties Primary Care
- Location West Lafayette, IN
- Active Since 06/30/2015
- Last Updated 09/06/2017
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1568845295
Products in Payments
- ENTRESTO (Drug) $278.29
- ELIQUIS (Drug) $265.80
- Kerendia (Drug) $173.93
- Ozempic (Drug) $169.07
- TRELEGY ELLIPTA (Drug) $166.38
- REXULTI (Drug) $130.10
- MOUNJARO (Drug) $103.77
- Rybelsus (Drug) $89.28
- FARXIGA (Drug) $77.57
- GVOKE PFS (Drug) $65.72
- INGREZZA (Drug) $56.95
- PREVNAR 20 (Biological) $52.15
- GEMTESA (Drug) $50.17
- PREMARIN (Drug) $42.83
- Veozah (Drug) $42.15
- GVOKE HYPOPEN (Drug) $33.71
- INSPIRE (Device) $32.29
- VERQUVO (Drug) $29.22
- KISUNLA (Drug) $27.45
- SPIRIVA RESPIMAT (Drug) $24.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in West Lafayette
Megan Rahn, Rn, Msn, RN, MSN
Registered Nurse — Payments: $1,605
Registered Nurse $1,605
Domanic Wiltermood, Fnp-C, FNP-C
Registered Nurse — Payments: $490.55
Registered Nurse $490.55
Katie Aldridge, Np, NP
Registered Nurse — Payments: $187.43
Registered Nurse $187.43
Kelly Murray, Msnp, MSNP
Registered Nurse — Payments: $183.83
Registered Nurse $183.83
Dr. Gwen Richardson, Phd Cfnp, PHD CFNP
Registered Nurse — Payments: $72.75
Registered Nurse $72.75
Ms. Kathy Hall, Registered Nurse, REGISTERED NURSE
Registered Nurse — Payments: $70.45
Registered Nurse $70.45